Related references
Note: Only part of the references are listed.Age-dependent prognostic effects of EGFR/p53 alterations in glioblastoma: study on a prospective cohort of 140 uniformly treated adult patients
M. R. Srividya et al.
JOURNAL OF CLINICAL PATHOLOGY (2010)
Genetic alterations and signaling pathways in the evolution of gliomas
Hiroko Ohgaki et al.
CANCER SCIENCE (2009)
Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience
R. Jalali et al.
BRITISH JOURNAL OF NEUROSURGERY (2007)
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Frank B. Furnari et al.
GENES & DEVELOPMENT (2007)
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome
M. Yoshimoto et al.
BRITISH JOURNAL OF CANCER (2007)
FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue
Roland A. Ventura et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2006)
Analysis of PTEN deletions and mutations in multiple myeloma
H Chang et al.
LEUKEMIA RESEARCH (2006)
Clinical utility of fluorescence in situ hybridization (FISH) in nonbrainstem glioblastomas of childhood
A Korshunov et al.
MODERN PATHOLOGY (2005)
The prognostic relevance of molecular alterations in glioblastomas for patients age < 50 years
A Korshunov et al.
CANCER (2005)
Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials
DJ Brat et al.
NEURO-ONCOLOGY (2004)
Molecular stratification of diagnostically challenging high-grade gliomas composed of small cells:: The utility of fluorescence in situ hybridization
A Korshunov et al.
CLINICAL CANCER RESEARCH (2004)
Small cell astrocytoma: An aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma
A Perry et al.
CANCER (2004)
Age-dependent prognostic effects of genetic alterations in glioblastoma
TT Batchelor et al.
CLINICAL CANCER RESEARCH (2004)
Molecular pathogenesis of astrocytic tumours
K Ichimura et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Abnormalities in chromosome 17 and p53 in lung carcinoma cells detected by fluorescence in situ hybridization
T Kawai et al.
PATHOLOGY INTERNATIONAL (2004)
Brain tumours: Classification and genes
VP Collins
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
Genetic pathways to glioblastoma:: A population-based study
H Ohgaki et al.
CANCER RESEARCH (2004)
Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features
CE Fuller et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
High-throughput molecular profiling of high-grade astrocytomas: The utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH)
CE Fuller et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
The WHO classification of tumors of the nervous system
P Kleihues et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: correlation with patient age and survival
K Tada et al.
JOURNAL OF NEUROSURGERY (2001)
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme
JS Smith et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis
H Sasaki et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Comprehensive allelotype and genetic analysis of 466 human nervous system tumors
A von Deimling et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2000)
Genetic alterations in adult diffuse glioma: Occurrence, significance, and prognostic implications
JS Smith et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2000)
Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas
H Fujisawa et al.
LABORATORY INVESTIGATION (2000)
Share Paper
